南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

造血系统中的HCAR2蛋白通过激活AMPK/ABCA1信号通路增强吞噬细胞吞噬功能,从而减轻动脉粥样硬化病变。

Hematopoietic HCAR2 attenuates atherosclerosis by enhancing efferocytosis via AMPK/ABCA1 signaling

Jiacheng Chen, Li Jiang, Fengying Zhang, Yan Luo, Bibiao Shen, Zhao Pan, Ping Zhang, ZhengYang Yuan, Yongjun Chen, Yangzhi Xie

Journal:INTERNATIONAL IMMUNOPHARMACOLOGY

IF:5.6

DOI:10.1016/j.intimp.2026.117417

PMID:

Published:2026-09-17

research field:

Abstract

HCAR2 links metabolic signals to inflammation resolution, offering a new strategy for cardiovascular risk beyond lipid-lowering. • HCAR2 reprograms macrophages via a non-canonical AMPK cascade, challenging AMPK's role as an energy gauge. • The HCAR2-AMPK-LXRα-ABCA1 axis links cholesterol metabolism to apoptotic cell clearance in atherosclerosis. Background Atherosclerotic plaque progression involves lipid accumulation, inflammation, and impaired efferocytosis, the macrophage mediated clearance of apoptotic cells. HCAR2, a metabolite sensing receptor highly expressed on macrophages, modulates immune metabolic responses, but its role in efferocytosis and atherosclerosis remains unclear. Methods APOE −/− and bone marrow chimeric mice were fed a high fat diet and treated with HCAR2 agonist MK-6892 or vehicle. Plaque size, composition, and efferocytic activity were assessed. Primary macrophages were evaluated for efferocytosis, lipid metabolism, cytokine release, and cholesterol efflux. Mechanistic studies included transcriptomics, immunoblotting, calcium imaging, and loss of function experiments. Results Compared to APOE −/− controls, APOE −/− mice lacking HCAR2 exhibited larger atherosclerotic plaques with increased lipid deposition, reduced collagen content, decreased smooth muscle cell coverage, and impaired efferocytosis. HCAR2 activation rescued the atherosclerotic phenotype and efferocytosis. Bone marrow transplantation confirmed that hematopoietic HCAR2 deficiency aggravated atherosclerosis. An in vitro study confirmed that HCAR2 restricted foam cell formation, inhibited the release of pro-inflammatory cytokines, promoted cholesterol efflux, and enhanced efferocytic activity. Mechanistically, HCAR2 signaling increased intracellular Ca 2+ and cAMP levels, activating the downstream Ca 2+ /CAMKK2/AMPK and PKA/LKB1/AMPK pathways, which subsequently upregulated LXRα/ABCA1 signaling. Lentiviral knockdown of ABCA1 blocked HCAR2-induced enhancement of macrophage

本文使用的Yeasen产品

购物车
客服
转染试用